MCH ADVISORY EQUITY RESEARCH
Institutional research — not investment advice ← Library
AJG SELL REF $255 PW TARGET $219 (-14% vs spot · 12m PWEV) -14% Single-name research · 8 July 2026
Equity ResearchFinancials · Insurance Brokers
AJG

Arthur J Gallagher & Co (AJG)

SELL. 12-month probability-weighted target $219 (-14% vs spot). P/E Multiple explains 72% of Monte Carlo outcome variance.

Verdict
SELL
Triangulated fair value $223 (-13% vs spot · triangulated FV)
Reference
$255
Close · 8 July 2026
PW Target
$219 (-14% vs spot · 12m PWEV) -14%
Probability-weighted
Horizon
12 mo
MCH Advisory
$223 (-13% vs spot · triangulated FV)
Fair value
$219 (-14% vs spot · 12m PWEV)
Scenario PWEV
18.6x
Forward P/E
$63B
Market cap
$190–$320
52-week range
Contents

Rating: SELL

SELL (5-tier) · mature cash generator · conviction: medium

Metric Value
Current Price $255
Triangulated Fair Value $223 (-13% vs spot · triangulated FV)
12-mo Scenario PWEV $219 (-14% vs spot · 12m PWEV)
Forward P/E 18.6x
Market Cap $63B
52-Week Range $190–$320

EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).


Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-27. Each chart below sits with the part of the thesis it evidences.

General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.

Investment Committee Summary

Rating SELL · SELL (5-tier)
Classification · conviction mature cash generator · medium
Triangulated fair value $223 (-13% vs spot · triangulated FV)
12-mo scenario PWEV $219 (-14% vs spot · 12m PWEV)
Next catalyst 2026-07-30 — Quarterly earnings
Primary thesis-break Brokerage organic revenue growth (reported quarterly) < 4.0% (2 consecutive prints)

📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.

Rating Bridge

Rating = SELL because:

  • Probability-weighted scenario value implies -14% vs spot
  • Monte Carlo median implies -22% vs spot
  • DCF fair value implies -5% vs spot — but this is terminal-value sensitive (exit-multiple $242 vs Gordon $300, 24% apart), so it carries less weight
  • Bear case (Structural — Soft-Market / Commission Pressure) downside is -56% vs spot
  • Net: reward/risk of 0.2× warrants a Sell.

Investment Thesis

At $229.57 (2026-06-27) AJG trades on 16.8x forward earnings against a broker-peer median of 14.7x. The market is paying a premium for a fee-based compounder: 7% growth, a 29% segment margin and a tuck-in machine that recycles capital at accretive multiples, with no underwriting risk. The engine agrees with the business quality but not the price. The probability-weighted target is $219.20, 4.5% below spot, and the Monte Carlo puts only a 32.9% probability on fair value above the current price. The drag is concentrated: 72% of simulation variance sits in the multiple, and a 20%-weighted structural soft-market scenario resolves to $111.44, well under the $190.12 52-week low. The DCF at $242.37 offers modest support but cannot offset that left tail. HOLD follows: the premium is earned, yet fully paid. The single most damaging risk is a P&C soft market compressing commissions and the premium multiple simultaneously.

The dashboard below is the whole argument on one page: spot ($255) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Integrated dashboard. The five valuation anchors bracket the $255 spot from <img src=
Integrated dashboard. The five valuation anchors bracket the $255 spot from $197 to $242 — stretched — spot sits above the skeptical blend.

Anti-Thesis (The Real Bear Case)

The structural bear case is mechanical, not speculative. Commissions are ad valorem: after several years of hard-market pricing, composite P&C rates roll negative and AJG's revenue base shrinks with no loss of clients. Compensation is sticky, so margin de-leverages from 29% toward 24% while fiduciary interest income fades with rates. The tuck-in arbitrage narrows at the same time, because seller multiples stay firm while AJG's own currency de-rates from 16.8x toward 10-11x, as the market reprices a cyclical revenue stream it had valued as a secular compounder. Earnings and the multiple compress together, and the $15.9B FY2025 investing outflow for AssuredPartners leaves less balance-sheet room to buy through the trough. That path lands near $111, beneath the 52-week low.

Key Debate

P/E Multiple explains 72% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q1): management +0.63 vs analyst floor +0.00 → delta +0.63 (n=27 mgmt / 18 Q&A; 92th pctile across the S&P book, z +1.4).

Flag: ELEVATED — management unusually upbeat vs the analyst floor relative to peers (disconfirmation watch).

Quarter Mgmt Analyst Delta
2026Q1 +0.63 +0.00 +0.63
2025Q4 +0.54 +0.12 +0.42
2025Q3 +0.34 +0.00 +0.34
2025Q2 +0.32 +0.03 +0.29

News (last 365d, 1000 articles): avg ticker sentiment +0.06 (bullish 13% / bearish 14%)

Scenario Analysis

The tree runs from a structural 'Structural — Soft-Market / Commission Pressure' downside ($112) to a 'Bull — Defensive Re-Rate' bull case ($343); the probability-weighted blend (PWEV $219) is -14% versus spot.

Scenario Probability Target Return vs spot
Structural — Soft-Market / Commission Pressure 20% $112 -56%
Economic / Exposure Recession 17% $180 -29%
Base — Organic + Pricing + M&A 35% $230 -10%
Growth — Specialty / International / Consolidation 20% $290 +14%
Bull — Defensive Re-Rate 8% $343 +35%
Probability-Weighted (PWEV) $219 -14%

Scenario rationale — what each probability buys (the driver path behind every target):

  • Structural — Soft-Market / Commission Pressure (20%, $112). Structural impairment — soft-market / commission pressure: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 111.44; probability: 0.2.
  • Economic / Exposure Recession (17%, $180). Cyclical downturn — brokerage organic growth + P&C pricing cycle + bolt-on M&A (fee/commission, no underwriting risk) weakens for 1–2 years before normalising. Drivers — implied_target: 180.26; probability: 0.17.
  • Base — Organic + Pricing + M&A (35%, $230). Mid-cycle — normalised brokerage organic growth + P&C pricing cycle + bolt-on M&A (fee/commission, no underwriting risk); disciplined capital allocation; steady returns. Drivers — implied_target: 230.51; probability: 0.35.
  • Growth — Specialty / International / Consolidation (20%, $290). Upside — specialty / international / consolidation lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 291.04; probability: 0.2.
  • Bull — Defensive Re-Rate (8%, $343). Upside tail — sustained tight conditions or a structural re-rate on specialty / international / consolidation. Drivers — implied_target: 342.3; probability: 0.08.
Five-scenario tree. Probability-weighted targets around the $255 spot; PWEV $219 (-14% vs spot · 12m). the payoff is skewed to the downside — upside to $343 against downside to <img src=
Five-scenario tree. Probability-weighted targets around the $255 spot; PWEV $219 (-14% vs spot · 12m). the payoff is skewed to the downside — upside to $343 against downside to $112

Valuation Triangulation

Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.

Method Basis Fair Value vs Spot
Monte Carlo median (Student-t + regime) multiple $197 -22%
Peer P/E re-rate multiple $202 -21%
Peer EV/Revenue re-rate multiple $230 -10%
Scenario PWEV multiple $219 -14%
DCF (5-year + terminal) cash flow + terminal × $242 -5%
Triangulated (weighted) $223 -13%

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

Monte Carlo — the distribution, not a point

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $197 and 22% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (72% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.

Monte Carlo distribution. Median <img src=
Monte Carlo distribution. Median $197; P(price > current) 22%. P10–P90: $122–$294.

DCF — the cash-flow anchor

Independent of the market multiple: a 5-year path, WACC 8.0%, 14x terminal FCF multiple → $242. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.

Independent DCF. WACC 8.0%, 14x terminal → $242.
Independent DCF. WACC 8.0%, 14x terminal → $242.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median forward multiple (P/E 14.73x) implies $202. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.

Cross-sectional peer benchmarking. Peer-median fwd P/E 14.73x → $202; EV/Rev re-rate → $230.
Cross-sectional peer benchmarking. Peer-median fwd P/E 14.73x → $202; EV/Rev re-rate → $230.

Across all anchors the spread is 20% of the median — moderate (healthy method disagreement — read the blend with care).

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Segment Revenue Mix Growth Op margin EBIT Multiple Capex % Tag
Insurance Brokerage $14.2B 100% 7% 29% $4.1B 16x 2% ESTIMATE
EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed).

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Dimension Assessment
driver brokerage organic growth + P&C pricing cycle + bolt-on M&A (fee/commission, no underwriting risk)
net_debt_or_cash_b 0.27

Capital intensity & shareholder returns (ESTIMATE)

Dimension Assessment
capex_pct_revenue 0.02
div_yield 0.012

Structural risk vs optionality (INFERENCE)

Dimension Assessment
downside soft-market / commission pressure
upside specialty / international / consolidation

Industry Context — Financials — Insurance Services

This name sits in the Financials — Insurance Services as a insurance_broker. brokerage organic growth + P&C pricing cycle + bolt-on M&A (fee/commission, no underwriting risk) Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.

Value chain: MRSH (insurance_broker) · AON (insurance_broker) · AJG (insurance_broker) · WTW (insurance_broker) · BRO (insurance_broker) · ERIE (insurance_broker)

Shared state Capex path House view This name implies
Soft-Market / Commission Pressure 37% 37%
Mid-Cycle — Organic + Pricing + M&A 35% 35%
Upside — Specialty / Consolidation 28% 28%

Mapping note: name-level 'Structural — Soft-Market / Commission Pressure' (20%) + 'Economic / Exposure Recession' (17%) map to cluster Soft-Market / Commission Pressure (37%); name-level 'Growth — Specialty / International / Consolidation' (20%) + 'Bull — Defensive Re-Rate' (8%) map to cluster Upside — Specialty / Consolidation (28%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.

On the cluster's key downside — Soft-Market / Commission Pressure () — this name implies 37% vs the cluster house view of 37% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.

Structure: Shared State — The fin_insurance_services cycle is the shared macro driver. Driver — brokerage organic growth + P&C pricing cycle + bolt-on M&A (no underwriting risk) Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).

Model Appendix

DCF — line items

Year Revenue Op income − Capex + D&A FCF PV(FCF)
FY+1 $15B $5B $0B $0B $4B $3B
FY+2 $16B $5B $0B $0B $4B $3B
FY+3 $17B $5B $0B $0B $4B $3B
FY+4 $18B $6B $0B $0B $4B $3B
FY+5 $19B $6B $0B $0B $5B $3B
Terminal $5B × 14x $44B

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 2% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 8.0% · Σ PV(FCF) $16B + PV(terminal) $44B = EV $60B; + net cash → equity $60B ÷ diluted shares 0.25B = $242/share (exit-multiple terminal).

  • Gordon (perpetuity-growth) terminal at 2.5% → $300/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
  • Incremental ROIC on the forecast capex ≈ 120% vs WACC 8% → above WACC — the build is value-creative.

Peer set

Peer EV/Rev Fwd P/E Growth Op margin
MRSH 3.598x 15.67x 7% 24%
AON 4.779x 17.15x 7% 36%
WTW 3.006x 13.79x 7% 20%
BRO 4.422x 13.26x 7% 47%
Median 4.01x 14.73x

Peer-median fwd P/E → $202; EV/Rev → $230.

Weighted fair-value math

Anchor Value Weight Contribution
DCF $242 41% $100
Scenario PWEV $219 29% $64
Monte Carlo median $197 18% $35
Peer P/E $202 12% $24
Triangulated 100% $223

Sensitivity

DCF/share — WACC × terminal multiple

WACC \ Term× 9.8x 11.9x 14.0x 16.1x 18.2x
6% $205 $234 $263 $292 $321
7% $197 $225 $252 $280 $308
8% $189 $216 $242 $268 $295
9% $182 $207 $232 $258 $283
10% $175 $199 $223 $247 $271

DCF/share — revenue CAGR Δ × op-margin Δ

CAGRΔ \ MgnΔ -3.0pp -1.5pp +0.0pp +1.5pp +3.0pp
-3.0pp $193 $203 $213 $223 $233
-1.5pp $206 $216 $227 $238 $249
+0.0pp $219 $231 $242 $254 $265
+1.5pp $233 $246 $258 $270 $282
+3.0pp $248 $261 $274 $287 $300

Tornado — DCF/share swing by driver (widest first)

Driver Low High Swing
Revenue CAGR ±3pp $213 $274 $61
Terminal × ±15% $216 $268 $53
Op margin ±3pp $219 $265 $46
WACC ±1pp $232 $252 $20
Capex intensity ±15% $240 $244 $3

Company lever — SoP/share vs Insurance Brokerage multiple (AI re-rating) (base 16x)

Multiple 11.2x 13.6x 16.0x 18.4x 20.8x
SoP/share $642 $780 $917 $1,055 $1,192

Consensus & Market Expectations

Reference Value
Street target (mean) $266 (+5% vs spot · street)
House target $219 (-17.7% vs street)
Sell-side coverage 22 analysts (SB 4 / B 13 / H 5 / S 0 / SS 0; net score 0.48)
Consensus FY EPS $14.87; house below (-7.9%)
Consensus FY revenue $18.3B; house below (-17.1%)

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Balance Sheet & Liquidity

Metric Value
Net debt $12.6B — highly levered
Net debt / EBITDA 3.18x
Interest coverage (EBIT / interest) 4.0x
Current ratio 1.06x
Lease obligations $0.5B
Cash & ST investments $1.4B

Balance-sheet data as of 2025-12-31 (Alpha Vantage).

Capital Allocation

Metric Value
Free cash flow $1.8B
Buybacks / dividends $1.5B / $0.7B
Total shareholder yield 3.4%
Payout as % of FCF 121.3%
Reinvestment (capex / OCF) 7.5%
SBC as % of FCF 2.7%
Allocation stance returning more than FCF (balance-sheet funded)

Free-Cash-Flow Quality

Metric Value
FCF margin 12.6%
FCF conversion (FCF / net income) 119.5%
FCF yield 2.8%
Capex intensity (capex / revenue) 1.0%
FCF − SBC (diagnostic) $1.7B
Capex split (maint / growth) 90% / 10% — Asset-light intermediary; physical capex is minimal (office/IT). Real capital deployment is M&A, which sits below the capex line. The maintenance-heavy split reflects a fee-based compounder, not a builder.

Accounting quality: SBC 0.3% of revenue; cash conversion (OCF/NI) 129% — cash-backed.

Catalyst Calendar

  • 2026-07-30 (~22d) — Quarterly earnings — est. EPS $2.86 (AV EARNINGS_CALENDAR)
  • 2026-09-15 (~69d) — Investor day / long-term organic-growth and margin targets (authored)
  • 2026-10-01 (~85d) — January 1 reinsurance renewal season pricing (Gallagher Re) (authored)
  • 2027-01-15 (~191d) — AssuredPartners / large-deal integration milestone (authored)

Forecast Track Record

  • EPS surprise: beat 62.5% of the last 8 quarters; average surprise +0.0%.

Competitive Moat

Wide moat. Gallagher's moat is wide: a fee/commission brokerage with ~90%+ client retention, scale in specialty and reinsurance broking, and a decades-proven tuck-in M&A machine that recycles capital at accretive multiples with no underwriting balance-sheet risk. A wide, capital-light compounder justifies a premium terminal multiple above the market - the ~17x forward P/E holds while organic growth stays mid-single-digit and M&A stays accretive; it should compress toward the broker-peer ~14-15x only if organic growth falls below ~4% or acquisition multiples paid exceed value created - falsified if organic + M&A growth sustains double-digit EPS compounding.

Moat sources:

  • ~90%+ client retention and recurring commission/fee revenue
  • Scale and data advantage in specialty and reinsurance broking (Gallagher Re)
  • Proven serial tuck-in M&A engine with a disciplined integration playbook
  • No underwriting risk - pure intermediary economics with high incremental margins
Issue Probability Valuation sensitivity Horizon
Broker compensation / contingent-commission transparency and conflict-of-interest scrutiny medium (~40%) medium - contingent commissions are high-margin; disclosure or curbs could clip ~4-6% of FV 12-24m
Antitrust / integration review on large brokerage acquisitions low (~25%) low - slows the M&A engine at the margin rather than impairing the base, ~2% of FV 12-24m

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

Scenario Macro assumption Key risk
Structural — Soft-Market / Commission Pressure A prolonged soft P&C market cuts premium rates, shrinking commission per placement while contingent commissions compress and the M&A pipeline dries up. Organic growth falling below ~4% permanently, removing the compounding that justifies the premium multiple and triggering de-rating.
Economic / Exposure Recession A broad economic downturn reduces insurable exposures (payrolls, revenues, fleets), lowering the base on which commissions are earned. Exposure-driven revenue decline compounding with client attrition in a recession, hitting the recurring-revenue assumption.
Base — Organic + Pricing + M&A Mid-single-digit organic growth, modest P&C rate firming, and continued accretive tuck-in M&A at historical multiples. Acquisition multiples paid creeping up faster than synergies delivered, quietly eroding return on invested capital.
Growth — Specialty / International / Consolidation Accelerated specialty and international share gains plus consolidation of a fragmented mid-market drive double-digit revenue compounding. Integration strain and cultural dilution from an elevated deal pace degrading the retention that underpins the moat.
Bull — Defensive Re-Rate In a risk-off tape, the market rewards AJG's fee-based, recession-resilient cash flows with a further multiple premium. A defensive re-rate is a tape-driven, not fundamentals-driven, gain and reverses when risk appetite returns.

What the Market Is Pricing In

At the current price, the market pays 17.1× forward EPS, vs the house DCF terminal 14.0×, and a peer median 14.73×. The house DCF sits 5% below spot, so the market is pricing in more than the house case — roughly 0.6pp of revenue CAGR.

Variant perception: the house view is below-consensus, and the thesis is primarily event-driven.

Metric Consensus House Importance
Revenue 18.3 15.2 High
EPS 14.9 13.7 Medium
Target price 266.4 219.2 Medium

Peer Quality & Weighting

Peer Fwd P/E Growth Op margin Quality Weight cap
MRSH 15.67× 7% 24% direct 100%
AON 17.15× 7% 36% direct 100%
WTW 13.79× 7% 20% segment 50%
BRO 13.26× 7% 47% segment 50%

Quality-weighted forward P/E: 15.4× (simple median 14.73×). Direct peers count 100%, segment 50%, broad 25%.

Historical-range cross-check: 52-week range $190–$320, centre $246 (-3% vs spot); spot sits at the 50th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

Metric Value
Upside to triangulated FV $223 (-13% vs spot · triangulated FV)
Downside to bear case (Structural — Soft-Market / Commission Pressure) $112 (-56% vs spot · bear scenario)
Reward/risk ratio 0.2×
Margin of safety (FV vs spot) -14%
P(price > spot) — Monte Carlo 22%

Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Defensive Re-Rate): $343.

Assumption Register

Assumption Value Used in Source
WACC 8.0% DCF discount rate estimate (CAPM)
Terminal multiple 14× DCF exit value estimate (peer-anchored)
Terminal growth 2.5% DCF Gordon terminal estimate
SBC dilution 0.0%/yr PWEV, MC, DCF (charged once) estimate (from SBC/rev)
EPS basis consensus forward EPS (broker-adjusted, non-GAAP) all forward P/E & scenario multiples definition

Sensitivity-ranked drivers (widest fair-value swing first): Revenue CAGR ±3pp (61.0); Terminal × ±15% (53.0); Op margin ±3pp (46.0); WACC ±1pp (20.0); Capex intensity ±15% (3.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Input Value Type Source Confidence Used in
Revenue TTM $14.2B reported fact 10-K/10-Q via AV High Forecast base, EV/Rev
FY+1 guided revenue $15.2B company guidance Company guidance Medium Forecast, SoP
Consensus FY EPS $14.8714 consensus estimate Sell-side consensus via AV Medium Variant perception
Diluted shares 0.249B reported fact 10-K via AV High Market cap, per-share
Net debt / cash $12.604B reported fact Balance sheet via AV High EV, DCF equity bridge
WACC 8.0% house estimate CAPM (beta/rf) Medium DCF discount rate
Terminal multiple 14× house estimate Peer/historical range Medium DCF exit value
Terminal growth 2.5% house estimate Long-run GDP+ Medium DCF Gordon terminal

Source Log

Source Type Date Used for Reference
Alpha Vantage — GLOBAL_QUOTE / OVERVIEW market data 2026-07-08 Price, market cap, EV, 52-week range, forward P/E Alpha Vantage 2026-06-27
Company income statement (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-08 Revenue, gross/operating margin, EBIT, interest expense INCOME_STATEMENT / latest annual
Company balance sheet (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-08 Cash, debt, net debt, leases, equity, coverage BALANCE_SHEET / latest annual
Company cash-flow statement (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-08 Operating cash flow, capex, FCF, buybacks, dividends, SBC CASH_FLOW / latest annual
Company earnings releases via Alpha Vantage reported fact 2026-07-08 Reported EPS, surprise history EARNINGS / quarterly
Sell-side consensus via Alpha Vantage consensus estimate 2026-07-08 Forward revenue/EPS consensus, analyst count EARNINGS_ESTIMATES
Earnings calendar via Alpha Vantage market data 2026-07-08 Next earnings date, catalyst timing EARNINGS_CALENDAR
Company guidance company guidance 2026-07-08 FY guided revenue / non-GAAP EPS basis company guidance / earnings call
MCH segment model (from filings & disclosures) house estimate 2026-07-08 Segment revenue, margins, multiples, AI decomposition company_context (authored, tagged)
MCH qualitative analysis inference 2026-07-08 Moat, regulatory risk, scenario macro, catalysts company_context enrichment (authored)
MCH investment thesis & falsification triggers house estimate 2026-07-08 Thesis, anti-thesis, thesis-break signals authored §5.3

Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.

Load-Bearing Assumptions

DCF: WACC 8%, terminal multiple 14×, FY+5 revenue $19B. Triangulation leans 41% on DCF, 29% on PWEV.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

  • Brokerage organic revenue growth (reported quarterly) < 4.0% (2 consecutive prints → Soft-Market / Commission Pressure). The base path carries 7% segment growth; the recession path 1%. Two prints of organic below the 4% midpoint indicate the P&C pricing tailwind has rolled over and the commission base is decelerating faster than the base path allows.
  • Global P&C renewal premium change (Gallagher composite) < 0% (2 consecutive prints → Soft-Market / Commission Pressure). Commissions are ad valorem on premium. A negative composite renewal premium change for two prints is the direct mechanical trigger for the structural soft-market scenario: revenue shrinks on flat client counts and margin de-leverages against a sticky compensation base.
  • Brokerage operating margin, engine basis < 28.0% (2 consecutive prints → Soft-Market / Commission Pressure). The base path assumes 29.1% and the recession path 27.0%. Two prints below the 28% midpoint mean compensation and integration costs are absorbing the revenue line faster than the base path tolerates, before any soft market arrives.
  • Annualised acquired revenue from completed tuck-in acquisitions (rolling four quarters) < $0.5B (2 consecutive prints → Mid-Cycle — Organic + Pricing + M&A). Bolt-on M&A supplies a material share of the 7% base-path growth. A stalled pipeline for two prints removes that leg and pushes the name toward the organic-only recession path even if pricing holds.
  • AssuredPartners integration: goodwill impairment or a cut to stated synergy / accretion guidance > any impairment charge or guidance reduction at a print (single event → Soft-Market / Commission Pressure). FY2025 investing cash outflow of $15.9B reflects the AssuredPartners consummation. An impairment or accretion cut would falsify the assumption that acquired revenue converts at Brokerage-level margins, and would drag the earnings base toward the structural path.

Fact / Inference / Speculation

  • FACT: Spot $255; 52-week range $190–$320; engine rating SELL; base-case target $219 (-14%). (source: Alpha Vantage 2026-06-27, 8 July 2026)
  • INFERENCE: Triangulated FV $223 (-13% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits above the multiple-discipline core.
  • SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.

Recommendation: SELL

Defensive: rating SELL; triangulated fair value $223 (-13% vs spot) — the risk/reward is skewed to the downside on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.

Disclosures & Limitations

This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.

  • No suitability assessment has been performed for any individual.
  • Market data may be delayed or inaccurate; figures are as of the analysis date.
  • Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
  • Forecasts are uncertain; past performance is not indicative of future returns.
  • The author or publisher may hold positions in securities mentioned.
  • Users should verify information against primary sources (company filings) before acting.
  • Investing involves risk of loss; there is no guarantee any target price is achieved.
  • Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.
Disclosures. This document is produced by MCH Advisory Services for informational and quantitative-research purposes only. It does not constitute investment, financial, legal or tax advice, nor an offer or solicitation to buy or sell any security. Price targets and probabilities are model outputs, not guarantees; past performance and backtested/simulated figures are not reliable indicators of future results. The author may hold positions in instruments mentioned and is not a registered financial adviser. Conduct your own due diligence and consult a qualified, registered adviser before making any investment decision.